LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Matulionyte, Raimonda"
  2. AU="Afshar, Sabereh"
  3. AU=Armstrong James PK AU=Armstrong James PK
  4. AU="Leshem, Shahaf"
  5. AU="García-García, Ana"
  6. AU="Terrón, Alberto"
  7. AU=Hanel Martin
  8. AU="Saro-Buendía, Miguel"
  9. AU="John R. Kouvaris"
  10. AU="Tripathy, Ashutosh"
  11. AU="Sharpley, Ann L"
  12. AU="Kragt, Lea"
  13. AU="Cui, Yanyan"
  14. AU="Morton, Jennifer P"

Suchergebnis

Treffer 1 - 10 von insgesamt 33

Suchoptionen

  1. Artikel ; Online: The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.

    Matulyte, Elzbieta / Davidaviciene, Edita / Kancauskiene, Zavinta / Diktanas, Saulius / Kausas, Aidas / Velyvyte, Daiva / Urboniene, Jurgita / Lipnickiene, Vilnele / Laurencikaite, Megan / Danila, Edvardas / Costagliola, Dominique / Matulionyte, Raimonda

    PloS one

    2023  Band 18, Heft 3, Seite(n) e0282046

    Abstract: Background: Tuberculosis (TB) is a public health problem in Lithuania, among the 18 high-priority TB countries in the European region, and the most common AIDS-indicative disease with the highest proportion in the EU/EEA since 2015. The study aimed to ... ...

    Abstract Background: Tuberculosis (TB) is a public health problem in Lithuania, among the 18 high-priority TB countries in the European region, and the most common AIDS-indicative disease with the highest proportion in the EU/EEA since 2015. The study aimed to identify socio-demographic, clinical characteristics and their relationship with TB outcomes in TB-HIV co-infected patients in Lithuania.
    Methods: A retrospective chart review analysed the characteristics of TB-HIV co-infected adults registered in State Information System of Tuberculosis over 2008-2020. The factors associated with drug-resistant TB and unsuccessful treatment outcome were identified by multivariable logistic regression.
    Results: The study included 345 cases in 311 patients (239 new, 106 previously treated cases), median age 40 years (IQR 35-45), 80.7% male. 67.8% patients knew their HIV-positive status before TB diagnosis, median time to TB diagnosis was 8 years (IQR 4-12). 83.6% were unemployed, 50.5%-anytime intravenous drug users (IDU), 34.9% abused alcohol. Drug-resistant TB rates in new and previously treated TB cases were 38.1% and 61.3%, respectively. In multivariable analysis, higher risk of drug-resistant TB was associated with imprisonment in new (aOR 3.35; 95%CI 1.17-9.57) and previously treated (aOR 6.63; 95%CI 1.09-40.35) cases. In 52.3% of new TB cases and in 42.5% previously treated TB cases the treatment outcomes were unsuccessful. In multivariable analysis of new TB cases, current imprisonment (aOR 2.77; 95%CI 1.29-5.91) and drug-resistant TB (aOR 2.18; 95%CI 1.11-4.28) were associated with unsuccessful treatment outcome. In multivariable analysis of previously treated TB cases, female gender (aOR 11.93; 95%CI 1.86-76.69), alcohol abuse (aOR 3.17; 95%CI 1.05-9.58), drug-resistant TB (aOR 4.83; 95%CI 1.53-15.28) were associated with unsuccessful treatment outcome.
    Conclusions: In the TB-HIV-infected adult cohort in Lithuania, unemployment, imprisonment, IDU, alcohol abuse, known to be risk factors for TB, were very frequent. Drug resistance was an undeniable risk factor for unsuccessful treatment outcome and imprisonment was associated with drug resistant TB.
    Mesh-Begriff(e) Adult ; Humans ; Male ; Female ; Retrospective Studies ; Lithuania/epidemiology ; Alcoholism/complications ; Antitubercular Agents/therapeutic use ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Tuberculosis/complications ; Tuberculosis/drug therapy ; Tuberculosis/epidemiology ; Risk Factors ; Treatment Outcome ; Tuberculosis, Multidrug-Resistant/complications ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/epidemiology ; Acquired Immunodeficiency Syndrome/drug therapy ; Demography
    Chemische Substanzen Antitubercular Agents
    Sprache Englisch
    Erscheinungsdatum 2023-03-23
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0282046
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Latent Tuberculosis Infection and Associated Risk Factors among People Living with HIV and HIV-Uninfected Individuals in Lithuania.

    Matulyte, Elzbieta / Kancauskiene, Zavinta / Kausas, Aidas / Urboniene, Jurgita / Lipnickiene, Vilnele / Kopeykiniene, Jelena / Gudaitis, Tomas / Raudonis, Sarunas / Danila, Edvardas / Costagliola, Dominique / Matulionyte, Raimonda

    Pathogens (Basel, Switzerland)

    2023  Band 12, Heft 8

    Abstract: Background: People living with HIV (PLHIV) with latent tuberculosis infection (LTBI) are at increased risk of tuberculosis (TB) reactivation compared to the HIV-negative population. Lithuania belongs to the 18 high-priority TB countries in the European ... ...

    Abstract Background: People living with HIV (PLHIV) with latent tuberculosis infection (LTBI) are at increased risk of tuberculosis (TB) reactivation compared to the HIV-negative population. Lithuania belongs to the 18 high-priority TB countries in the European region. The aim of this study was to compare the prevalence of LTBI and LTBI-related risk factors between PLHIV and HIV-uninfected populations.
    Methods: A cross-sectional study was conducted in three Lithuanian Infectious Diseases centres from August 2018 to May 2022 using the interferon gamma release assay (IGRA) and tuberculin skin test (TST) in Vilnius, and IGRA only in Siauliai and Klaipeda. Cohen's kappa was used to assess IGRA and TST agreement. A structured questionnaire was completed by the study participants. LTBI-related risk factors were identified using a multivariable logistic regression model.
    Results: In total, 391 PLHIV and 443 HIV-uninfected individuals enrolled, with a median age of 41 (IQR 36-48) and 43 (IQR 36-50), consisting of 69.8% and 65.5% male, respectively. The prevalence of LTBI defined by positive IGRA and/or TST among PLHIV was higher compared to that in the HIV-uninfected population (20.5% vs. 15.3%; OR 1.42; 95% CI 1.02-2.03;
    Conclusions: The prevalence of LTBI among PLHIV in Lithuania is higher compared to that in the HIV-uninfected population and the European average. The association with IDU in PLHIV emphasizes the need for integrated HIV, TB and substance abuse treatment to provide patient-centred care.
    Sprache Englisch
    Erscheinungsdatum 2023-07-28
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2695572-6
    ISSN 2076-0817
    ISSN 2076-0817
    DOI 10.3390/pathogens12080990
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis.

    Matulionytė, Raimonda / Žagminas, Kęstutis / Balčiūnaitė, Eglė / Matulytė, Elžbieta / Paulauskienė, Rasutė / Bajoriūnienė, Almina / Ambrozaitis, Arvydas

    BMC infectious diseases

    2019  Band 19, Heft 1, Seite(n) 21

    Abstract: Background: HIV transmission remains a major concern in Eastern Europe, and too many people are diagnosed late. Expanded testing strategies and early and appropriate access to care are required. Infectious disease departments might be targets for ... ...

    Abstract Background: HIV transmission remains a major concern in Eastern Europe, and too many people are diagnosed late. Expanded testing strategies and early and appropriate access to care are required. Infectious disease departments might be targets for expanded HIV testing owing to the intense passage of key patient populations that carry indicators of HIV disease. Our objective was to evaluate the feasibility and clinical effectiveness of a fully integrated, opt-out routine, rapid HIV testing program.
    Methods: A retrospective four-year study of a screening program was conducted from 2010 through 2014. The program was divided into two periods: from 2010 to 2012 (pilot study) and from 2013 to 2014. The pilot study consisted of routine HIV testing of patients aged 18-55 that were hospitalized in one department. In the second period, all inpatients aged 18-65 were eligible. Targeted testing was conducted in the other inpatient department during the pilot study and the outpatient department during both periods.
    Results: During the pilot study, 2203 patients were hospitalized, 1314 (59.6%) were eligible, 954 (72.6%) were tested, and 3 (0.31%) were newly diagnosed HIV-positive. In the second period, 4911 patients were hospitalized, 3727 (75.9%) were eligible, 3303 (88.6%) were tested, and 7 (0.21%) were HIV-positive. In total, 2800 targeted tests were performed, and 4 (0.14%) patients tested positive with newly discovered HIV. All 14 newly diagnosed patients were provided with care. Comparing cumulative groups of routine and targeted testing, the HIV prevalence was 0.23% vs. 0.14% (p = 0.40) and was above the reported cost-effectiveness threshold of 0.1% (p = 0.012). A lower proportion of advanced disease and a higher proportion of heterosexually transmitted infection were found in the routine testing group.
    Conclusion: Routine HIV testing in admissions of infectious diseases is acceptable, feasible, sustainable and clinically effective. Compared to targeted testing, routine testing helped to discover more patients in earlier stages and those with heterosexually transmitted HIV infection.
    Mesh-Begriff(e) Adolescent ; Adult ; Aged ; Communicable Diseases ; Cost-Benefit Analysis ; Female ; HIV Infections/diagnosis ; HIV Infections/epidemiology ; Heterosexuality ; Hospitalization ; Hospitals, Teaching/statistics & numerical data ; Humans ; Inpatients ; Lithuania/epidemiology ; Male ; Mass Screening/organization & administration ; Middle Aged ; Pilot Projects ; Prevalence ; Retrospective Studies ; Universities
    Sprache Englisch
    Erscheinungsdatum 2019-01-07
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2041550-3
    ISSN 1471-2334 ; 1471-2334
    ISSN (online) 1471-2334
    ISSN 1471-2334
    DOI 10.1186/s12879-018-3661-0
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: HIV disease metrics and COVID-19 infection severity and outcomes in people living with HIV in central and eastern Europe.

    Oprea, Cristiana / Quirke, Siobhan / Ianache, Irina / Bursa, Dominik / Antoniak, Sergii / Bogdanic, Nikolina / Vassilenko, Anne I / Aimla, Kersti / Matulionyte, Raimonda / Rukhadze, Nino / Harxhi, Arjan / Fleischhans, Lukáš / Lakatos, Botond / Sedlacek, Dalibor / Dragovic, Gordana / Verhaz, Antonija / Yancheva, Nina / Acet, Oguzhan / Protopapas, Konstantinos /
    Kowalska, Justyna Dominika

    HIV medicine

    2023  Band 25, Heft 3, Seite(n) 343–352

    Abstract: Background: To date there remains much ambiguity in the literature regarding the immunological interplay between SARS-CoV-2 and HIV and the true risk posed to coinfected individuals. There has been little conclusive data regarding the use of CD4 cell ... ...

    Abstract Background: To date there remains much ambiguity in the literature regarding the immunological interplay between SARS-CoV-2 and HIV and the true risk posed to coinfected individuals. There has been little conclusive data regarding the use of CD4 cell count and HIV viral load stratification as predictors of COVID-19 severity in this cohort.
    Methods: We performed a retrospective, observational cohort study on people living with HIV (PLWH) who contracted COVID-19 in central and eastern Europe. We enrolled 536 patients from 16 countries using an online survey. We evaluated patient demographics, HIV characteristics and COVID-19 presentation and outcomes. Statistical analysis was performed using SPSS 20.1.
    Results: The majority of the study cohort were male (76.4%) and 152 (28.3%) had a significant medical comorbidity. Median CD4 cell count at COVID-19 diagnosis was 605 cells/μL [interquartile range (IQR) 409-824]. The majority of patients on antiretroviral therapy (ART) were virally suppressed (92%). In univariate analysis, CD4 cell count <350 cells/μL was associated with higher rates of hospitalization (p < 0.0001) and respiratory failure (p < 0.0001). Univariate and multivariate analyses found that an undetectable HIV VL was associated with a lower rate of hospitalization (p < 0.0001), respiratory failure (p < 0.0001), ICU admission or death (p < 0.0001), and with a higher chance of full recovery (p < 0.0001).
    Conclusion: We can conclude that detectable HIV viral load was an independent risk factor for severe COVID-19 illness and can be used as a prognostic indicator in this cohort.
    Mesh-Begriff(e) Humans ; Male ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; Retrospective Studies ; COVID-19 Testing ; COVID-19/epidemiology ; COVID-19/complications ; SARS-CoV-2 ; CD4 Lymphocyte Count ; Europe, Eastern ; Respiratory Insufficiency ; Viral Load
    Sprache Englisch
    Erscheinungsdatum 2023-11-28
    Erscheinungsland England
    Dokumenttyp Observational Study ; Journal Article
    ZDB-ID 2001932-4
    ISSN 1468-1293 ; 1464-2662
    ISSN (online) 1468-1293
    ISSN 1464-2662
    DOI 10.1111/hiv.13578
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Oral manifestations of HIV disease: A review.

    Aškinytė, Daiva / Matulionytė, Raimonda / Rimkevičius, Arūnas

    Stomatologija

    2015  Band 17, Heft 1, Seite(n) 21–28

    Abstract: The HIV/AIDS pandemic continues to plague the world. Evaluation of oral health status is important at every stage in the management of HIV disease. Oral health services and professionals can contribute effectively to the control of HIV/AIDS through ... ...

    Abstract The HIV/AIDS pandemic continues to plague the world. Evaluation of oral health status is important at every stage in the management of HIV disease. Oral health services and professionals can contribute effectively to the control of HIV/AIDS through health education, patient care, infection control and surveillance. Dental professionals have an important task of determining accurate diagnosis of oral manifestations and choosing proper treatment for each case. This review provides information on HIV associated orofacial lesions, their clinical presentation and up to date treatment strategies.
    Mesh-Begriff(e) AIDS-Related Opportunistic Infections/diagnosis ; AIDS-Related Opportunistic Infections/therapy ; Acquired Immunodeficiency Syndrome/complications ; HIV Infections/complications ; Humans ; Mouth Diseases/complications ; Mouth Diseases/diagnosis ; Mouth Diseases/therapy ; Periodontal Diseases/diagnosis ; Periodontal Diseases/therapy ; Tooth Diseases/diagnosis ; Tooth Diseases/therapy
    Sprache Englisch
    Erscheinungsdatum 2015
    Erscheinungsland Lithuania
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2416227-9
    ISSN 1822-301X ; 1392-8589
    ISSN (online) 1822-301X
    ISSN 1392-8589
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: National multi-stakeholder meetings: a tool to support development of integrated policies and practices for testing and prevention of HIV, viral hepatitis, TB and STIs.

    Simões, Daniel / Matulionyté, Raimonda / Stoniene, Loreta / Wysocki, Piotr / Kowalska, Justyna / Gasbarrini, Nadia / Cosmaro, Lella / Blažić, Tatjana Nemeth / Dišković, Arian / Dominković, Zoran / Jovovic, Iva / Razmiene, Ilona / Maffeo, Manuel / Jakobsen, Stine F

    BMC infectious diseases

    2021  Band 21, Heft Suppl 2, Seite(n) 795

    Abstract: Background: Country level policies and practices of testing and care for HIV, viral hepatitis and sexually transmitted infections are lagging behind European recommendations on integration across diseases. Building on previous experiences and evidence, ... ...

    Abstract Background: Country level policies and practices of testing and care for HIV, viral hepatitis and sexually transmitted infections are lagging behind European recommendations on integration across diseases. Building on previous experiences and evidence, the INTEGRATE Joint Action arranged four national stakeholder meetings. The aim was to foster cross-disciplinary and cross-disease collaborations at national level as a vehicle for strengthened integration of testing and care services. This article presents the methodology and discusses main outcomes and recommendations of these meetings.
    Methods: Local partners in Croatia, Italy, Lithuania and Poland oversaw the planning, agenda development and identification of key persons to invite to ensure that meetings addressed main challenges and issues of the respective countries. Invited national stakeholders represented policy and public health institutions, clinical settings, testing sites and community organisations. National experts and experts from other European countries were invited as speakers and facilitators. Main topic discussed was how to increase integration across HIV, viral hepatitis and sexually transmitted infections in testing and care policies and practice; tuberculosis was also addressed in Lithuania and Italy.
    Results: The agendas reflected national contexts and the meetings provided a forum to engage stakeholders knowledgeable of the national prevention, testing and care systems in interaction with international experts who shared experiences of the steps needed to achieve integration in policies and practice. The evaluations showed that participants found meetings relevant, important and beneficial for furthering integration. Of the respondents 78% agreed or strongly agreed that there was a good representation of relevant national stakeholders, and 78% that decision/action points were made on how to move the agenda forward. The importance of securing participation from high level national policy makers was highlighted. Outcomes were nationally tailored recommendations on integrated policies and strategies, diversification of testing strategies, stigma and discrimination, key populations, cost effectiveness, surveillance and funding.
    Conclusions: Shifting from single to multi-disease approaches require collaboration among a broad range of actors and national multi-stakeholder meetings have proven excellent to kick-start this. Face-to-face meetings of key stakeholders represent a unique opportunity to share cross-sectoral perspectives and experiences, identify gaps in national policies and practices and agree on required next steps.
    Mesh-Begriff(e) HIV Infections/diagnosis ; HIV Infections/prevention & control ; Health Policy ; Hepatitis, Viral, Human/diagnosis ; Hepatitis, Viral, Human/epidemiology ; Hepatitis, Viral, Human/prevention & control ; Humans ; Sexually Transmitted Diseases/diagnosis ; Sexually Transmitted Diseases/prevention & control ; Social Stigma
    Sprache Englisch
    Erscheinungsdatum 2021-09-13
    Erscheinungsland England
    Dokumenttyp Journal Article
    ISSN 1471-2334
    ISSN (online) 1471-2334
    DOI 10.1186/s12879-021-06492-y
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future.

    Gokengin, Deniz / Bursa, Dominik / Skrzat-Klapaczynska, Agata / Alexiev, Ivailo / Arsikj, Elena / Balayan, Tatevik / Begovac, Josip / Cicic, Alma / Dragovic, Gordana / Harxhi, Arjan / Aimla, Kerstin / Lakatos, Botond / Matulionyte, Raimonda / Mulabdic, Velida / Oprea, Cristiana / Papadopoulos, Antonios / Rukhadze, Nino / Sedlacek, Dalibor / Sojak, Lubomir /
    Tomazic, Janez / Vassilenko, Anna / Vasylyev, Marta / Verhaz, Antonija / Yancheva, Nina / Yurin, Oleg / Kowalska, Justyna

    Vaccines

    2023  Band 11, Heft 1

    Abstract: With no expected vaccine for HIV in the near future, we aimed to define the current situation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central and Eastern Europe (CEE). The Euroguidelines CEE Network Group members were ... ...

    Abstract With no expected vaccine for HIV in the near future, we aimed to define the current situation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central and Eastern Europe (CEE). The Euroguidelines CEE Network Group members were invited to respond to a 27-item survey including questions on PrEP (response rate 91.6%). PrEP was licensed in 68.2%; 95 centers offered PrEP and the estimated number on PrEP was around 9000. It was available in daily (40.1%), on-demand (13.3%), or both forms (33.3%). The access rate was <1−80%. Three major barriers for access were lack of knowledge/awareness among people who are in need (59.1%), not being reimbursed (50.0%), and low perception of HIV risk (45.5%). Non-occupational PEP was available in 86.4% and was recommended in the guidelines in 54.5%. It was fully reimbursed in 36.4%, only for accidental exposures in 40.9%, and was not reimbursed in 22.72%. Occupational PEP was available in 95.5% and was reimbursed fully. Although PrEP scale-up in the region has gained momentum, a huge gap exists between those who are in need of and those who can access PrEP. Prompt action is required to address the urgent need for PrEP scale-up in the CEE region.
    Sprache Englisch
    Erscheinungsdatum 2023-01-04
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines11010122
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV-Data from ECEE Network Group.

    Aimla, Kerstin / Kowalska, Justyna Dominika / Matulionyte, Raimonda / Mulabdic, Velida / Vassilenko, Anna / Bolokadze, Natalie / Jilich, David / Antoniak, Sergii / Oprea, Cristiana / Balayan, Tatevik / Harxhi, Arjan / Papadopoulos, Antonios / Lakatos, Botond / Vasylyev, Marta / Begovac, Josip / Yancheva, Nina / Streinu-Cercel, Anca / Verhaz, Antonija / Gokengin, Deniz /
    Dragovic, Gordana / Sojak, Lubomir / Skrzat-Klapaczyńska, Agata

    Vaccines

    2023  Band 11, Heft 5

    Abstract: 1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare testing, ... ...

    Abstract (1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare testing, prophylaxis and treatment of viral hepatitis in PLWH in Central and Eastern Europe (CEE) in 2019 and 2022. (2) Methods: Data was collected through two on-line surveys conducted in 2019 and 2022 among 18 countries of the Euroguidelines in CEE (ECEE) Network Group. (3) Results: In all 18 countries the standard of care was to screen all PLWH for HBV and HCV both years; screening of HAV was routine in 2019 in 54.5% and in 2022 47.4% of clinics. Vaccination of PLWH against HAV was available in 2019 in 16.7%, in 2022 in 22.2% countries. Vaccination against HBV was available routinely and free of charge in 50% of clinics both in 2019 and 2022. In HIV/HBV co-infected the choice of NRTI was tenofovir-based in 94.4% of countries in both years. All clinics that responded had access to direct-acting antivirals (DAAs) but 50% still had limitations for treatment. (4) Conclusions: Although testing for HBV and HCV was good, testing for HAV is insufficient. Vaccination against HBV and especially against HAV has room for improvement; furthermore, HCV treatment access needs to overcome restrictions.
    Sprache Englisch
    Erscheinungsdatum 2023-05-14
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines11050980
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.

    Chammartin, Frédérique / Mocroft, Amanda / Egle, Alexander / Zangerle, Robert / Smith, Colette / Mussini, Cristina / Wit, Ferdinand / Vehreschild, Jörg Janne / d'Arminio Monforte, Antonella / Castagna, Antonella / Bailly, Laurent / Bogner, Johannes / de Wit, Stéphane / Matulionyte, Raimonda / Law, Matthew / Svedhem, Veronica / Tallada, Joan / Garges, Harmony P / Marongiu, Andrea /
    Borges, Álvaro H / Jaschinski, Nadine / Neesgaard, Bastian / Ryom, Lene / Bucher, Heiner C

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2023  Band 78, Heft 4, Seite(n) 995–1004

    Abstract: Background: Human immunodeficiency virus (HIV) infection leads to chronic immune activation/inflammation that can persist in virally suppressed persons on fully active antiretroviral therapy (ART) and increase risk of malignancies. The prognostic role ... ...

    Abstract Background: Human immunodeficiency virus (HIV) infection leads to chronic immune activation/inflammation that can persist in virally suppressed persons on fully active antiretroviral therapy (ART) and increase risk of malignancies. The prognostic role of low CD4:CD8 ratio and elevated CD8 cell counts on the risk of cancer remains unclear.
    Methods: We investigated the association of CD4:CD8 ratio on the hazard of non-AIDS defining malignancy (NADM), AIDS-defining malignancy (ADM) and most frequent group of cancers in ART-treated people with HIV (PWH) with a CD4 and CD8 cell counts and viral load measurements at baseline. We developed Cox proportional hazard models with adjustment for known confounders of cancer risk and time-dependent cumulative and lagged exposures of CD4:CD8 ratio to account for time-evolving risk factors and avoid reverse causality.
    Results: CD4:CD8 ratios below 0.5, compared to above 1.0, were independently associated with a 12-month time-lagged higher risk of ADM and infection-related malignancies (adjusted hazard ratio 2.61 [95% confidence interval {CI }1.10-6.19] and 2.03 [95% CI 1.24-3.33], respectively). CD4 cell counts below 350 cells/μL were associated with an increased risk of NADMs and ADMs, as did infection, smoking, and body mass index-related malignancies.
    Conclusions: In ART-treated PWH low CD4:CD8 ratios were associated with ADM and infection-related cancers independently from CD4 and CD8 cell counts and may alert clinicians for cancer screening and prevention of NADM.
    Mesh-Begriff(e) Humans ; Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/drug therapy ; HIV ; HIV Infections/complications ; HIV Infections/drug therapy ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Neoplasms/complications ; Neoplasms/epidemiology ; Neoplasms/drug therapy ; CD4-CD8 Ratio ; Viral Load ; Anti-HIV Agents/adverse effects
    Chemische Substanzen Anti-Retroviral Agents ; Anti-HIV Agents
    Sprache Englisch
    Erscheinungsdatum 2023-12-14
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciad671
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Two dog-related infections leading to death: overwhelming Capnocytophaga canimorsus sepsis in a patient with cystic echinococcosis.

    Matulionytė, Raimonda / Lisauskienė, Ingrida / Kėkštas, Gintautas / Ambrozaitis, Arvydas

    Medicina (Kaunas, Lithuania)

    2012  Band 48, Heft 2, Seite(n) 112–115

    Abstract: Capnocytophaga canimorsus is a fastidious, capnophilic, fusiform, and filamentous gram-negative rod. It is part of the normal oral flora of dogs and cats and can cause an infection in humans, but is of generally low virulence in healthy individuals. A ... ...

    Abstract Capnocytophaga canimorsus is a fastidious, capnophilic, fusiform, and filamentous gram-negative rod. It is part of the normal oral flora of dogs and cats and can cause an infection in humans, but is of generally low virulence in healthy individuals. A case of fatal sepsis due to Capnocytophaga canimorsus in a 46-year-old woman with clinically silent cystic echinococcosis discovered postmortem is present. She had been bitten by a dog 3 days before the symptoms appeared. The family had owned the dog for 4 years. A preliminary diagnosis of septic shock of unknown etiology with multisystem organ failure was established. Despite all the efforts, the patient died on the seventh day of hospitalization. Laboratory findings received postmortem showed Capnocytophaga canimorsus isolated from the blood culture after 7 incubation days. Autopsy showed a cyst in the liver with a fibrotic wall and necrotic eosinophilic interiors containing fragments of Echinococcus granulosus scolices. In conclusion, an interaction possibly established long ago between the host and Echinococcus granulosus conditioned immunosuppression mechanisms developed by the parasite in this case, which can explain such an aggressive course of the infection with Capnocytophaga. Two dog-related infections were fatal in the middle-aged dog owner considered healthy before this hospitalization. Vigilance concerning recent exposure to dogs or cats and potential immunosuppression risk factors must be maintained in a patient presenting with clinical features of fulminant sepsis.
    Mesh-Begriff(e) Animals ; Bites and Stings/microbiology ; Capnocytophaga/isolation & purification ; Dogs ; Echinococcosis/complications ; Echinococcosis/immunology ; Fatal Outcome ; Female ; Gram-Negative Bacterial Infections/complications ; Gram-Negative Bacterial Infections/diagnosis ; Gram-Negative Bacterial Infections/microbiology ; Humans ; Immune Tolerance ; Kidney/microbiology ; Kidney/pathology ; Liver/microbiology ; Liver/pathology ; Middle Aged ; Multiple Organ Failure/complications ; Multiple Organ Failure/diagnosis ; Multiple Organ Failure/microbiology ; Necrosis ; Sepsis/complications ; Sepsis/diagnosis ; Sepsis/microbiology
    Sprache Englisch
    Erscheinungsdatum 2012
    Erscheinungsland Netherlands
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 2188113-3
    ISSN 1648-9144 ; 1010-660X
    ISSN (online) 1648-9144
    ISSN 1010-660X
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang